[Comparative clinical evaluation of the effectiveness and tolerance of a new antihypertensive agent, DL 150 IT, administered alone and in combination with reserpine or propranolol].
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D004983:Ethanolamines; D011724:Pyridazines; D012110:Reserpine; D011433:Propranolol; C006198:oxdralazine
Valutazione clinica comparativa dell'efficacia e della tollerabilità del nuovo antiipertensivo DL 150 IT somministrato da solo ed in associazione a reserpina o propranololo.